China To Unveil New Edition Of Drug GMPs Early Next Year
This article was originally published in PharmAsia News
Executive Summary
China's State FDA will release a draft of the new edition of drug good manufacturing practices to solicit public feedback early next year. The revision focuses on GMP safety, effectiveness and controllable quality, emphasizing the soft aspects to allow better applicability and to remove ambiguity. The draft enforces stricter file management and defines concepts such as drug quality authorization person, design verification, change management and deviation handling. Except for clean-room drug production, standards for other drug manufacturing facilities remain unchanged. Compatible with the latest Drug Registration Regulation and Administrative Measures for Drug Recalls, the draft also enhances GMP links with drug registration and post-marketing supervision, so as to strengthen the relationship between supervision of drug production and registration. (Click here for more - Chinese Language)
You may also be interested in...
EU: Good News For IVDs And For Future Transparency Of Medtech Compliance
The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.